이달의 증례

HOME

자료실
이달의 증례
Aortic Stenosis and Transcatheter Aortic Valve Implantation: Current Status and Future Directions in Korea
년도 2019년 4월
카테고리 이달의 kcj Hot Article
저자 Choongki Kim, MD,1,2 and Myeong-Ki Hong, MD, PhD1,3
소속 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. 2Department of Cardiology, Ewha Womans University Seoul Hospital, Seoul, Korea. 3Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea.
첨부파일 1 kcj-49-283-g001-l.jpg
  • 관리자
  • 등록일 : 2019.03.25
  • Hit 129
Abstract

Transcatheter aortic valve implantation (TAVI) has been accepted as one of primary options for treatment of symptomatic severe aortic stenosis. Although TAVI has been predominantly used for patients at high risk or with old age who were not considered optimal candidates for surgical aortic valve replacement (SAVR), its indication is now expanding toward low risk profile and younger age. Many clinical trials are now ongoing to test the possibility of TAVI for use in patients even with uncharted indications who are not eligible for SAVR in current guidelines but may benefit from valve replacement. Current issues including periprocedural safety, long-term adverse events, hemodynamics and durability associated with TAVI should be also solved for expanding use of TAVI. The review presents current status and future directions of TAVI and discusses perspectives in Korea.

Keywords:
Aortic valve stenosisTranscatheter aortic valve replacement

 

원문보기 : https://www.e-kcj.org/DOIx.php?id=10.4070/kcj.2019.0044

 

 

댓글 0